hotspot -WSS

hotspot

author：leisure time 2025-09-30 18:59:42 - browse：6646

The sign of University of Texas MD Anderson Cancer Center in Houston, Texas in front of the Sheikh Zayed Building — coverage from STAT — Adobe

Early last year, MD Anderson Cancer Center leadership had a problem on their hands: a contentious dispute between one of its most powerful researchers and a junior scientist over authorship, credit, and charges of verbal abuse. High-ranking officials at the cancer center tried — and failed — to resolve the feud, and documents obtained by STAT shed new light on the deep divisions at the heart of this case.

The Texas cancer center outsourced assessing the conflict between early-career nephrologist Jamie Lin and leading oncologist Padmanee Sharma to the law firm Ropes & Gray. The firm investigated the authorship and scientific credit portions of the dispute and concluded that Sharma was likely responsible for a scientific hypothesis at the heart of the feud and should be named as a co-senior author on a key manuscript.

But a separate investigation, commissioned by Lin and conducted by a former official at the federal Office of Research Integrity, tells a somewhat different story. That review looked into plagiarism after Sharma claimed Lin had wrongly omitted the senior researcher as an author from a manuscript built on research to which Sharma contributed. But this second investigation found no evidence of plagiarism between two manuscripts submitted to the journals Cancer Immunology Research and Journal of Clinical Investigation Insight.

Lin provided STAT with copies of an executive summary of the Ropes & Gray investigation as well as the conclusions of the plagiarism investigation. These documents are alluded to in legal filings but have not been previously reported. Lin has filed a lawsuit against Sharma in the Harris County District Court alleging retaliation, harassment, threatening, and intellectual theft by Sharma; she’s also asking for $5 million in damages.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： The effects of a landmark ruling on DNA ownership are becoming clearer

leisure time

focus

WSS

HHS's proposed rule does nothing to address the climate crisis

Is it ever OK for doctors to lie to their patients?

Brain MRIs reveal impact of 'toxic stress' on Black children

Chemotherapy before breast cancer surgery might fuel metastasis

Analysis of telehealth claims data suggest service duplication

Stroke deaths set to near 10 million globally by 2050

hotspot

hotspot

leisure time

Duchenne breakthrough therapy leaves behind pioneering families

Senate panel eyes new effort on drug shortages

Tori Bowie and the unacceptable rates of Black maternal death

Readout Newsletter: PTC, Dyne, Rapport, Cytokinetics news

Medicare details structure of new drug price negotiation program

PBM executives asked to testify by House panel

Psychedelics group wrestles with new pharma identity

Lawmakers grill UnitedHealth CEO on Change cyberattack

Hepatitis C has a cure — but many Americans still lack access to it

Warren pushes Witty on UnitedHealth's control over physicians

knowledge

Chemotherapy before breast cancer surgery might fuel metastasis

Sepsis can kill a child within hours. Here's how hospitals are fighting back

Colorectal cancer study finds potential in overlooked immune cell

Senate panel eyes new effort on drug shortages

Primary care doctor shortage won't be solved by free med school tuition

In $4.8 billion deal, Bristol Myers Squibb to buy cancer player Mirati

explore

leisure time

focus

entertainment